Medical/Pharmaceuticals
Transcenta to Present Interim Safety and Efficacy Data of the TST001 and Chemotherapy Combination Expansion Cohort for Claudin18.2 Positive First Line Gastric Cancer at ESMO Congress 2022
SUZHOU, China, July 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the interim safe...
2022-07-28 08:00
3358
Clarius Applauded by Frost & Sullivan with 2022 North American Portable Ultrasound Technology Innovation Leadership Award for Enabling High-Quality and More Affordable Ultrasound Imaging With its HD3 App-Based Scanners
The Clarius HD3 App-Based Ultrasound Scanners accurately recognize different structures in the human torso during the scanning process and auto adjusts settings to optimize imaging. SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Recently Frost & Sullivan analyzed the North American portable ultrasou...
2022-07-27 23:17
3045
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging
Telix and BAMF Health use Illuccix® (kit for the preparation of Gallium Ga 68 gozetotide injection) for the first time with uEXPLORER® total-body PET scanner for prostate cancer imaging GRAND RAPIDS, Mich. and INDIANAPOLIS, July 27, 2022 /PRNewswire/ -- The PSMA-PET[1] imaging agent Illuccix® fr...
2022-07-27 20:30
3146
NCCN Publishes New Patient Guidelines for Breast Cancer Screening and Diagnosis Emphasizing Annual Mammograms for All Average-Risk Women Over 40
The free evidence-based, expert consensus resource, available at NCCN.org/patientguidelines, helps people ask the right questions about when and how often to screen. PLYMOUTH MEETING, Pa., July 27, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) has published new NCCN Gu...
2022-07-27 20:07
2505
Bushu Pharma Lauded by Frost & Sullivan for Enabling the Launch of Specialty Drugs in Japan and Asia-Pacific and Offering Customer Value with Its Advanced Gateway to Asia Services
The Gateway to Asia initiative ensures quality and timely delivery through shorter lead times, temperature and humidity control, and streamlined urgent order processing SAN ANTONIO, July 27, 2022 /PRNewswire/ -- Based on its recent analysis of the pharmaceutical supply chain contract services in...
2022-07-27 14:03
2440
Brii Biosciences Announces Positive Data Demonstrating its Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, Retains Neutralizing Activity Against Live Omicron Virus BA.4/5 and BA.2.12.1 Subvariants
Independent lab results demonstrate that the combination therapy retains neutralizing activity against currently dominant COVID-19 strains, as previously demonstrated with all variants of concern to date The amubarvimab/romlusevimab combination is commercially available in China and is under rev...
2022-07-27 07:00
4467
EDAN Launches Next-Gen ABG Solutions for the Clinic During 2022 AACC
A lightweight POC CO-oximetry blood gas and chemistry system i20 reveals how
photoluminescence biosensor coupled with microfluidics could transform the
future of ABG tests in clinical departments.
CHICAGO, July 26, 2022 /PRNewswire/ -- EDAN Instruments, Inc.
2022-07-26 23:47
3473
Sustainable Manufacturing Practices: The Key to Mitigating Antimicrobial Resistance
JAKARTA, Indonesia, July 26, 2022 /PRNewswire/ -- Centrient Pharmaceuticals, a global business-to-business leader in sustainable, enzymatic antibiotics manufacturing, in partnership with Menjangan Sakti, a trader of pharmaceutical raw materials inIndonesia, organized a workshop on 'Sustainability...
2022-07-26 21:45
2769
ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW
Company receives top customer rating in the 2022 IMV ServiceTrak™ Awards SAN DIEGO, July 26, 2022 /PRNewswire/ -- QuidelOrtho Corporation (NASDAQ: QDEL) ("QuidelOrtho") announced today that its subsidiary,Ortho Clinical Diagnostics, a leading provider of in vitro diagnostics solutions and service...
2022-07-26 21:35
2717
Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America
The commercial agreement to promote and sell CHORUS TRIO immunometric assay solutions in the U.S. Market was announced jointly by the two companies during the AACC Annual Scientific Meeting & Clinical Lab Expo inChicago. CHICAGO, July 26, 2022 /PRNewswire/ -- Menarini Silicon Biosystems Inc, a US...
2022-07-26 21:00
2329
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
SINGAPORE, July 26, 2022 /PRNewswire/ -- Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus (MPXV), for research use only (RUO). The ViroKey® MPXV PCR Test allows for the prompt, in vitro detection of MPXV DNA from human skin lesion specimens. It is com...
2022-07-26 21:00
2935
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
* Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents inJapan GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious d...
2022-07-26 20:05
3302
Henlius HANQUYOU Received TGA Approval in Australia
SHANGHAI, July 26, 2022 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's business partner Cipla Limited ("Cipla") has received the relevant registration certificates from the Therapeutic Goods Administration ofAustralia ("TGA") for the approval of Henlius' sel...
2022-07-26 18:03
4814
Sirnaomics Receives IND Clearance from the "Taiwan Ministry of Health and Welfare" for Phase I Clinical Study of RNAi Therapeutic STP705 for Liver Cancer Treatment
GAITHERSBURG, Md. and SUZHOU, China, July 26, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that the Company has received regulatory clearance from t...
2022-07-26 16:58
3678
Intellect partners with Swiss Life Network to expand reach of comprehensive mental health care solutions in Asia
* Intellect joins hands with leading global employee benefits providers, Swiss Life Network * This partnership brings Intellect's comprehensive mental health solutions to workforces across APAC through Swiss Life Network's Clients and Network Partners SINGAPORE, July 26, 2022 /PRNewswire/ -- ...
2022-07-26 15:52
4013
Manulife enhances Cashless Day Surgery eService to diversify its comprehensive healthcare support
Expansion of specialist network, medical service providers, and categories of surgeries under eight major specialties offers customers more convenient quality health services HONG KONG, July 26, 2022 /PRNewswire/ -- Manulife Hong Kong today announced it has enhanced its Cashless Day Surgery eSer...
2022-07-26 12:33
4945
Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon(R) Platform
EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell ...
2022-07-26 11:51
2711
Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong
Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI®, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and med...
2022-07-26 08:30
3811
CSafe Global Continues Investment in Cell and Gene Therapy Solutions with Addition of New Portfolio President
Amy DuRoss joins CSafe Global as President, Cell & Gene Therapy to drive innovation and solution development MONROE, Ohio, July 26, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced...
2022-07-26 03:35
4291
Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform
* Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissues * Rona licensed Sanofi's siRNA platform to enable discovery programs in expanded therapeutic areas including neuro and muscular diseases, for which Sanofi has an exclusive option to acquire neu...
2022-07-25 12:30
4382
Week's Top Stories
Most Reposted
DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 277 media titles]
2026-10-06 05:28SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 276 media titles]
2026-10-07 11:50Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 271 media titles]
2026-10-01 10:00
Vestas Powers Up Vietnam's Clean Energy Ambitions with Two New Projects Under PDP8 Totaling 16 Wind Turbines
[Picked up by 263 media titles]
2026-10-02 16:27
Southeast Asia's China travel map is widening, Traveloka platform data shows
[Picked up by 262 media titles]
2026-10-05 11:51Most Read
MixVio AI Launches Unified Creative Workspace Across 26 AI Generation Routes
2026-10-02 00:30
23969